Germany’s Stada Arzneimittel AG is poised to substantially bolster its OTC portfolio in Central and Eastern Europe (CEE) and gain a foothold for further expansion across the region with the acquisition of Czech Republic-based Walmark a.s.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?